8400 The Health Network
Ilan Oren is a seasoned executive with extensive experience in the life sciences sector. Currently serving as Chairman of the Board and a Board Member at Roivant Sciences since 2014, Ilan Oren has also held key leadership positions at Dexcel Pharma as Co-Chief Executive Officer and VP of Business Development since 2011. Additional board memberships include Clexio Biosciences, Kriya Therapeutics, and 8400 - The Health Network. Previously, Ilan Oren contributed to Axovant Gene Therapies, Ltd and Cynapsus Therapeutics as a Board Member. Early career experience includes a consulting role at L.E.K. Consulting within the Life Sciences Practice. Ilan Oren is an alumnus of Harvard University, where an AB in Economics was earned.
This person is not in any teams
8400 The Health Network
On a mission to drive an Israeli economic growth engine in HealthTech and accelerate global cure, 8400 The Health Network is weaving a network of HealthTech ecosystem leaders, across silos and sectors, who learn together and create gap-closing projects that will propel a thriving HealthTech industry in Israel. The 8400 Fellowship runs annual cohorts of 60 senior Israeli leaders each, for an intensive 17 day program across 7 months. The program’s tailor-made curriculum is creating a continuous platform for breaking silos, peer learning and designing ecosystem growth initiatives. 8400 fellowship graduates join the 8400 Network.